MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy
Tóm tắt
MLP (muscle LIM protein)-deficient mice count among the first mouse models for dilated cardiomyopathy (DCM), yet the exact role of MLP in cardiac signalling processes is still enigmatic. Elevated PKCα signalling activity is known to be an important contributor to heart failure. Here we show that MLP directly inhibits the activity of PKCα. In end-stage DCM, PKCα is concentrated at the intercalated disc of cardiomyocytes, where it is sequestered by the adaptor protein CARP in a multiprotein complex together with PLCβ1. In mice deficient for both MLP and CARP the chronic PKCα signalling chain at the intercalated disc is broken and they remain healthy. Our results suggest that the main role of MLP in heart lies in the direct inhibition of PKCα and that chronic uninhibited PKCα activity at the intercalated disc in the absence of functional MLP leads to heart failure.
Từ khóa
Tài liệu tham khảo
Arber, S., Halder, G. & Caroni, P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79, 221–231 (1994).
Schneider, A., Sultan, K. & Pette, D. Muscle LIM protein: expressed in slow muscle and induced in fast muscle by enhanced contractile activity. Am. J. Physiol. 276, C900–C906 (1999).
Schmeichel, K. L. & Beckerle, M. C. The LIM domain is a modular protein-binding interface. Cell 79, 211–219 (1994).
Li, A., Ponten, F. & dos Remedios, C. G. The interactome of LIM domain proteins: the contributions of LIM domain proteins to heart failure and heart development. Proteomics 12, 203–225 (2012).
Arber, S. & Caroni, P. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev. 10, 289–300 (1996).
Flick, M. & Konieczny, S. The muscle regulatory and structural protein MLP is a cytoskeletal binding partner of bI-spectrin. J. Cell Sci. 113, 1553–1564 (2000).
Ehler, E. et al. Alterations at the intercalated disk associated with the absence of muscle LIM protein. J. Cell Biol. 153, 763–772 (2001).
Knöll, R. et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111, 943–955 (2002).
Kong, Y., Flick, M. J., Kudla, A. J. & Konieczny, S. F. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol. Cell. Biol. 17, 4750–4760 (1997).
Boateng, S. Y., Senyo, S. E., Qi, L., Goldspink, P. H. & Russell, B. Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein. J. Mol. Cell. Cardiol. 47, 426–435 (2009).
Geier, C. et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum. Mol. Genet. 17, 2753–2765 (2008).
Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393–403 (1997).
Boateng, S. Y. et al. Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein. Am. J. Physiol. Heart Circ. Physiol. 292, H259–H269 (2007).
Hoffmann, C. et al. Human muscle LIM protein dimerizes along the actin cytoskeleton and cross-links actin filaments. Mol. Cell. Biol. 34, 3053–3065 (2014).
Minamisawa, S. et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313–322 (1999).
Heineke, J. et al. Calcineurin protects the heart in a murine model of dilated cardiomyopathy. J. Mol. Cell. Cardiol. 48, 1080–1087 (2010).
Rockman, H. A. et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc. Natl Acad. Sci. USA 95, 7000–7005 (1998).
Fajardo, G. et al. Deletion of the beta2-adrenergic receptor prevents the development of cardiomyopathy in mice. J. Mol. Cell. Cardiol. 63, 155–164 (2013).
Braz, J. C. et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248–254 (2004).
Hambleton, M. et al. Pharmacological- and gene therapy-based inhibition of protein kinase calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation 114, 574–582 (2006).
Palaniyandi, S. S., Sun, L., Ferreira, J. C. & Mochly-Rosen, D. Protein kinase C in heart failure: a therapeutic target? Cardiovasc. Res. 82, 229–239 (2009).
van Berlo, J. H., Maillet, M. & Molkentin, J. D. Signalling effectors underlying pathologic growth and remodeling of the heart. J. Clin. Invest. 123, 37–45 (2013).
Belin, R. J. et al. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ. Res. 101, 195–204 (2007).
Hidalgo, C. et al. PKC phosphorylation of titin’s PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ. Res. 105, 631–638 (2009).
Kirchhefer, U. et al. Protein phosphatase 2A is regulated by protein kinase Calpha (PKCalpha)-dependent phosphorylation of its targeting subunit B56alpha at Ser41. J. Biol. Chem. 289, 163–176 (2014).
Zhang, Q. C. et al. Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature 490, 556–560 (2012).
Zolk, O., Caroni, P. & Bohm, M. Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation 101, 2674–2677 (2000).
D’Angelo, D. D. et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc. Natl Acad. Sci. USA 94, 8121–8126 (1997).
Bowling, N. et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 99, 384–391 (1999).
Simonis, G. et al. Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol. Cell. Biochem. 305, 103–111 (2007).
Zolk, O. et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem. Biophys. Res. Commun. 293, 1377–1382 (2002).
Mikhailov, A. T. & Torrado, M. The enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease. Int. J. Dev. Biol. 52, 811–821 (2008).
Kojic, S., Radojkovic, D. & Faulkner, G. Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease. Crit. Rev. Clin. Lab. Sci. 48, 269–294 (2011).
Miller, M. K. et al. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J. Mol. Biol. 333, 951–964 (2003).
Jasnic-Savovic, J. et al. Profiling of skeletal muscle Ankrd2 protein in human cardiac tissue and neonatal rat cardiomyocytes. Histochem. Cell Biol. 143, 583–597 (2015).
Belgrano, A. et al. Multi-tasking role of the mechanosensing protein Ankrd2 in the signalling network of striated muscle. PLoS ONE 6, e25519 (2011).
Schnabel, P., Gas, H., Nohr, T., Camps, M. & Bohm, M. Identification and characterization of G protein-regulated phospholipase C in human myocardium. J. Mol. Cell. Cardiol. 28, 2419–2427 (1996).
Jeyaseelan, R. et al. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J. Biol. Chem. 272, 22800–22808 (1997).
Lun, A. S., Chen, J. & Lange, S. Probing muscle ankyrin-repeat protein (MARP) structure and function. Anat. Rec. 297, 1615–1629 (2014).
Song, Y. et al. Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-beta signalling pathways. PLoS ONE 7, e50436 (2012).
Bang, M. L. et al. The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload. PLoS ONE 9, e93638 (2014).
Schoenauer, R. et al. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res. Cardiol. 106, 233–247 (2011).
Pluess, M., Daeubler, G., dos Remedios, C. G. & Ehler, E. Adaptations of cytoarchitecture in human dilated cardiomyopathy. Biophys. Rev. 7, 25–32 (2015).
Kuhn, C. et al. Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP). Basic Res. Cardiol. 107, 262 (2012).
Hutchinson, K. R., Saripalli, C., Chung, C. S. & Granzier, H. Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling. J. Mol. Cell. Cardiol. 79, 104–114 (2015).
Bogomolovas, J. et al. Induction of Ankrd1 in dilated cardiomyopathy correlates with the heart failure progression. Biomed. Res. Int. 2015, 273936 (2015).
Zhong, L. et al. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy. Cardiovasc. Res. 106, 261–271 (2015).
Sheikh, F. et al. An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J. Clin. Invest. 118, 3870–3880 (2008).
Arimura, T. et al. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 54, 334–342 (2009).
Moulik, M. et al. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J. Am. Coll. Cardiol. 54, 325–333 (2009).
Crocini, C. et al. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue. Basic Res. Cardiol. 108, 349 (2013).
Newton, A. C. Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 298, E395–E402 (2010).
Jalili, T. et al. PKC translocation without changes in Galphaq and PLC-beta protein abundance in cardiac hypertrophy and failure. Am. J. Physiol. 277, H2298–H2304 (1999).
Hahn, H. S. et al. Protein kinase Calpha negatively regulates systolic and diastolic function in pathological hypertrophy. Circ. Res. 93, 1111–1119 (2003).
El-Armouche, A. & Eschenhagen, T. Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail. Rev. 14, 225–241 (2009).
Dilly, K. W. et al. Overexpression of beta2-adrenergic receptors cAMP-dependent protein kinase phosphorylates and modulates slow delayed rectifier potassium channels expressed in murine heart: evidence for receptor/channel co-localization. J. Biol. Chem. 279, 40778–40787 (2004).
Dorn, G. W. 2nd & Force, T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115, 527–537 (2005).
Kinoshita, E., Kinoshita-Kikuta, E., Takiyama, K. & Koike, T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol. Cell. Proteomics 5, 749–757 (2006).
Ehler, E., Moore-Morris, T. & Lange, S. Isolation and culture of neonatal mouse cardiomyocytes. J. Vis. Exp. 79, 50154 (2013).